INCY Incyte Corporation - Common Stock

NASDAQ · Biotechnology · SEC EDGAR'da Görüntüle ↗
$128,11
Fiyat · Ağu 20, 2026
Temel veriler itibarıyla Tem 28, 2026
52 Haftlık Aralık
$81–$133
91% of range
Analist Derecelendirmesi
HOLD
33 analysts
Fiyat Hedefi
$125
P/E (TTM)
20.0
ROE
27.6%
Net Kâr Marjı
25.0%

Incyte Corporation - Common Stock Hakkında Wikipedia'dan şirket genel bakışı

Incyte Corporation is an American multinational pharmaceutical company with headquarters in Wilmington, Delaware. The company currently operates manufacturing and R&D locations in North America, Europe, and Asia.

Devamını oku

Incyte Corporation is an American multinational pharmaceutical company with headquarters in Wilmington, Delaware. The company currently operates manufacturing and R&D locations in North America, Europe, and Asia.

Incyte Corporation currently develops and manufactures prescription biopharmaceutical medications in multiple therapeutic areas including oncology, inflammation, and autoimmunity.

History

Incyte Corporation was founded by Roy A. Whitfield on April 8, 1991, in Palo Alto, California, as a genomics company. It became a public company in 1993. Subsequently, scientists and chemists were recruited from DuPont to work for Incyte. Incyte moved its headquarters to Delaware, and acquired Maxia Pharmaceuticals in 2003.

In November 2013, Incyte announced its relocation to new headquarters in Wilmington, Delaware, completing the move by the end of 2014. Hervé Hoppenot became CEO in January 2014.

In 2017, the company became part of the S&P 500 Index, which tracks the 500 most widely held U.S. stocks.

In 2015, Incyte established its European headquarters in Geneva, Switzerland, and later moved this headquarters in 2021. The company expanded its Delaware headquarters, including the addition of a research and development facility, in 2022. Incyte acquired Villaris Therapeutics in 2022, and Escient Pharmaceuticals in 2024.

For 2025, the company reported $5.141 billion in revenue, $6.957 billion in assets and $1.286 billion in net income. Incyte is publicly traded on the NASDAQ under the symbol INCY. Incyte now operates out of North America, Asia, and Europe. Bill Meury became CEO in 2025. Meury replaced Hoppenot, who retired after 11 years in the position.

Pharmaceuticals

Incyte Corporation currently has seven marketed and co-marketed pharmaceutical products, including Jakafi (ruxolitinib), Pemazyre (pemigatinib), Monjuvi (tafasitamab-cxix), Opzelura (Ruxolitinib), Tabrecta (capmatinib), Olumiant (Baricitinib), and Iclusig (ponatinib).

In 2013, Novartis acquired Incyte's c-Met inhibitor capmatinib (INC280, INCB028060), which is marketed under the brand name Tabrecta.

As of 2014, the company was developing baricitinib, an oral JAK1 and JAK2 inhibitor drug for rheumatoid arthritis in partnership with Eli Lilly. It gained EU approval in February 2017. In April 2017, the US FDA issued a rejection, citing concerns about dosing and safety. In May 2018, baricitinib was approved in the United States for the treatment of rheumatoid arthritis under the brand name Olumiant.

As of 2016 epacadostat, an indoleamine 2,3-dioxygenase (IDO1) inhibitor, was in development for various cancers and was in combination trials with Merck's pembrolizumab (Keytruda) and Bristol Myers Squibb's nivolumab (Opdivo).

Acquisition history

Incyte has made a total of 3 acquisitions.

Maxia Pharmaceuticals (2003): An early acquisition in Incyte's history, the company purchased Maxia in 2003 for $42 million.

Villaris Therapeutics (2022): This acquisition was valued at approximately $1.4 billion and included an upfront payment along with milestones. It added new assets to Incyte's portfolio for treating vitiligo and other autoimmune conditions.

Escient Pharmaceuticals (2024): In May 2024, Incyte acquired this San Diego-based, clinical-stage company for $750 million. The acquisition provided Incyte with two oral drug candidates for inflammatory diseases, EP262 and EP547.

Kaynak: Wikipedia (İngilizce), CC BY-SA 4.0 · Wikipedia'da Görüntüle ↗

Wikidata ↗

INCY Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık

Fiyat
$128.11
Piyasa Değeri
$25.42B
P/E (TTM)
20.0
EPS (TTM)
$6.41
Gelir (TTM)
$5.14B
Temettü Verimi
—
ROE
27.6%
D/E Borç/Özsermaye
—
52 Haftlık Aralık
$81 – $133

INCY Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin

10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri

Gelir ve Net Gelir $5.14B
10-point trend, +365.0%
2016-12-31 → 2025-12-31
Hisse Başına Kâr $6.41
10-point trend, +1087.0%
2016-12-31 → 2025-12-31
Serbest Nakit Akışı —
6-point trend, +537.3%
2017-12-31 → 2022-12-31
Marjlar 25.0%

Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?

Metrik
5 Yıllık trend
INCY
Akran Ortalaması
P/E (TTM)
5-point trend, -10.4%
20.0
17.7
P/S (TTM) (F/S (TTM))
5-point trend, -46.7%
4.9
6.8
P/B (F/D)
5-point trend, -48.1%
4.9
6.4

Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC

Metrik
5 Yıllık trend
INCY
Akran Ortalaması
Operating Margin (Faaliyet Kâr Marjı)
5-point trend, +397.9%
29.5%
—
Net Profit Margin (Net Kâr Marjı)
5-point trend, +325.7%
25.0%
20.3%
ROA
5-point trend, +345.3%
20.8%
11.4%
ROE
5-point trend, +333.2%
27.6%
16.8%
ROIC
5-point trend, +276.2%
22.7%
—

Finansal Sağlık Borç, likidite, solventlik — bilanço gücü

Metrik
5 Yıllık trend
INCY
Akran Ortalaması
Current Ratio (Cari Oran)
5-point trend, -11.3%
3.3
3.4
Quick Ratio (Cari Oran)
5-point trend, -14.7%
2.0
—

Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR

Metrik
5 Yıllık trend
INCY
Akran Ortalaması
Revenue YoY (Gelir Yıllık Bazda)
5-point trend, +72.2%
21.2%
—
Revenue CAGR 3Y (Gelir 3 Yıllık Bileşik Büyüme Oranı)
5-point trend, +72.2%
14.8%
—
Revenue CAGR 5Y (Gelir 5 Yıllık Bileşik Büyüme Oranı)
5-point trend, +72.2%
14.0%
—
EPS YoY (EPS YB)
5-point trend, +50.1%
4173.3%
—
Net Income YoY (Net Gelir Yıllık Bazda)
5-point trend, +35.6%
3845.0%
—

Hisse Başı Metrikler Hisse Başı Kâr, hisse başına defter değeri, hisse başına nakit akışı, hisse başına temettü

Metrik
5 Yıllık trend
INCY
Akran Ortalaması
EPS (Diluted) (Hisse Başına Kar (Seyreltilmiş))
5-point trend, +50.1%
$6.41
—

Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı

Metrik
5 Yıllık trend
INCY
Akran Ortalaması

INCY Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel

AL 33 analist
  • Güçlü Al 8 24,2%
  • Al 9 27,3%
  • Tut 16 48,5%
  • Sat 0 0,0%
  • Güçlü Sat 0 0,0%

12 Aylık Fiyat Hedefi

23 analist · 2026-08-18
Medyan hedef $120.00 -6,3%
Ortalama hedef $125.17 -2,3%

Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi

Ort. Sürpriz
0.33%
Dönem EPS Gerçek EPS Tahmin Sürpriz
30 Haziran 2026 $3.09 $2.14 0.95%
31 Mart 2026 $1.81 $1.40 0.41%
31 Aralık 2025 $1.80 $1.97 -0.17%
30 Eylül 2025 $2.26 $1.69 0.57%
30 Haziran 2025 $1.57 $1.50 0.07%
31 Mart 2025 $1.16 $1.04 0.12%

Akran karşılaştırması (GICS alt sektörü) Anahtar metrikler sektördeki benzerlerine karşı

Hisse Sembolü Piyasa Değeri P/E Gelir YoY Net Kar Marjı ROE Brüt Kar Marjı
INCY $19.60B 15.4 21.2% 25.0% 27.6% —
NTRA $32.00B -150.7 35.9% -9.0% -14.1% —
RVMD — — — — — —
BIIB $25.84B 20.0 2.2% 13.1% 7.2% —
ALNY $52.64B 170.7 65.2% 8.5% 60.4% —
INSM $37.29B -27.1 66.7% -210.5% -128.4% —
UTHR $21.27B 17.5 10.6% 41.9% 18.7% 87.9%
BBIO $14.90B -20.2 126.3% -146.0% 41.2% —
NBIX $14.20B 30.4 21.4% 16.7% 16.1% —
EXEL $11.44B 15.7 7.0% 33.7% 37.3% —
BMRN $11.43B 33.0 12.9% 10.8% 5.8% —

Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı

Gelir Tablosu 17
INCY için Yıllık Gelir Tablosu verileri
Metrik Eğilim 202520242023202220212020201920182017201620152014
Revenue 12-point trend, +905.1% $5.14B $4.24B $3.70B $3.39B $2.99B $2.67B $2.16B $1.88B $1.54B $1.11B $754M $511M
Cost of Revenue 12-point trend, +12287.8% $372M $312M $255M $207M $151M $131M $114M $94M $79M $58M $27M $3M
R&D Expense 12-point trend, +489.9% $2.05B $2.61B $1.63B $1.59B $1.46B $2.22B $1.15B $1.20B $1.33B $582M $480M $348M
SG&A Expense 12-point trend, +730.2% $1.38B $1.24B $1.16B $1.00B $740M $517M $469M $434M $366M $303M $197M $166M
Operating Expenses 12-point trend, +602.4% $3.63B $4.18B $3.08B $2.82B $2.40B $2.93B $1.76B $1.75B $1.78B $961M $703M $516M
Operating Income 12-point trend, +31633.3% $1.51B $61M $621M $579M $586M $-264M $402M $129M $-243M $145M $51M $-5M
Interest Expense 10-point trend, -94.6% · · $3M $3M $2M $2M $2M $2M $7M $39M $46M $47M
Interest Income 4-point trend, +161.1% $106M $129M $158M $40M · · · · · · · ·
Other Non-op 9-point trend, +46.4% $25M $13M $14M $-519.0K $11M $23M $52M $32M $17M · · ·
Pretax Income 12-point trend, +3528.5% $1.66B $317M $834M $529M $570M $-232M $487M $115M $-312M $107M $8M $-49M
Income Tax 12-point trend, +572525.8% $378M $284M $237M $188M $-378M $63M $40M $6M $852.0K $3M $1M $-66.0K
Net Income 10-point trend, +1134.5% $1.29B $33M $598M $341M $949M $-296M $447M $109M $-313M $104M · ·
EPS (Basic) 12-point trend, +2372.4% $6.59 $0.16 $2.67 $1.53 $4.30 $-1.36 $2.08 $0.52 $-1.53 $0.55 $0.04 $-0.29
EPS (Diluted) 12-point trend, +2310.3% $6.41 $0.15 $2.65 $1.52 $4.27 $-1.36 $2.05 $0.51 $-1.53 $0.54 $0.03 $-0.29
Shares (Basic) 12-point trend, +16.2% 195,204,000 207,110,000 223,628,000 222,004,000 220,428,000 218,073,000 214,913,000 212,383,000 204,580,000 187,873,000 179,601,000 167,947,000
Shares (Diluted) 12-point trend, +19.5% 200,700,000 210,530,000 225,928,000 223,958,000 222,074,000 218,073,000 217,657,000 215,635,000 204,580,000 194,125,000 187,302,000 167,947,000
EBITDA 9-point trend, +4292.8% $1.61B $151M · $647M $644M $-212M $457M $184M $-192M · · $37M
Bilanço 27
INCY için Yıllık Bilanço verileri
Metrik Eğilim 202520242023202220212020201920182017201620152014
Cash & Equivalents 12-point trend, +584.9% $3.10B $1.69B $3.21B $2.95B $2.06B $1.51B $1.83B $1.16B $900M $652M $521M $452M
Short-term Investments 6-point trend, +92.5% · · · · · · $285M $274M $270M $156M $186M $148M
Inventory 12-point trend, +28129.1% $101M $59M $63M $42M $28M $16M $11M $7M $6M $4M $2M $358.0K
Prepaid Expense 12-point trend, +1449.0% $318M $169M $183M $167M $126M $60M $44M $79M $62M $33M $18M $21M
Current Assets 12-point trend, +639.3% $5.02B $3.24B $4.65B $4.09B $3.12B $2.36B $2.48B $1.83B $1.50B $994M $842M $680M
PP&E (Net) 12-point trend, +793.6% $731M $763M $752M $739M $724M $560M $378M $320M $260M $168M $86M $82M
PP&E (Gross) 12-point trend, +849.6% $1.11B $1.09B $1.02B $952M $900M $704M $499M $423M $334M $219M $131M $116M
Accum. Depreciation 12-point trend, +981.7% $375M $328M $270M $213M $176M $144M $122M $103M $75M $52M $45M $35M
Goodwill 10-point trend, -14.5% $133M $156M $156M $156M $156M $156M $156M $156M $156M $156M · ·
Intangibles 4-point trend, +11535.6% · · · · · · · · $237M $270M $12M $2M
Other Non-current Assets 11-point trend, +47.9% $18M $11M $52M $25M $37M $39M $49M $19M $2M $3M $12M ·
Total Assets 12-point trend, +773.6% $6.96B $5.44B $6.78B $5.84B $4.93B $3.56B $3.43B $2.65B $2.30B $1.64B $1.01B $796M
Accounts Payable 12-point trend, +758.2% $210M $197M $110M $278M $172M $99M $84M $104M $68M $76M $30M $24M
Accrued Liabilities 12-point trend, +1556.5% $1.03B $1.21B $936M $701M $534M $378M $286M $229M $199M $127M $87M $62M
Current Liabilities 12-point trend, +585.4% $1.52B $1.64B $1.24B $1.16B $854M $631M $513M $425M $375M $274M $168M $221M
Capital Leases 7-point trend, +22.4% $15M $17M $14M $14M $16M $14M $12M · · · · ·
Deferred Tax · · · · · · · · · · · $20M
Other Non-current Liabilities 12-point trend, +203.0% $165M $168M $149M $99M $70M $58M $40M $22M $20M $13M $48M $55M
Total Liabilities 12-point trend, +103.9% $1.79B $2.00B $1.59B $1.47B $1.16B $950M $828M $720M $672M $1.22B $836M $878M
Long-term Debt 5-point trend, +2170.7% · · · · · · · $19.09B $27M $750M $750M $841M
Total Debt · · · · · · · · · · · $689M
Common Stock 12-point trend, +15.8% $198.0K $193.0K $224.0K $223.0K $221.0K $219.0K $216.0K $213.0K $211.0K $189.0K $187.0K $171.0K
Retained Earnings 12-point trend, +112.0% $214M $-1.07B $160M $-437M $-778M $-1.73B $-1.43B $-1.88B $-1.99B $-1.67B $-1.78B $-1.79B
AOCI 12-point trend, +1302.9% $25M $-13M $13M $15M $-19M $-15M $-16M $-10M $-7M $-3M $-809.0K $2M
Stockholders' Equity 12-point trend, +6430.5% $5.17B $3.45B $5.19B $4.37B $3.77B $2.61B $2.60B $1.93B $1.63B $419M $171M $-82M
Liabilities + Equity 12-point trend, +773.6% $6.96B $5.44B $6.78B $5.84B $4.93B $3.56B $3.43B $2.65B $2.30B $1.64B $1.01B $796M
Shares Outstanding 12-point trend, +16.1% 198,460,009 193,434,305 224,286,862 222,746,719 221,084,433 219,489,329 216,177,830 213,274,660 211,262,906 188,848,752 186,650,249 170,876,619
Nakit Akışı 16
INCY için Yıllık Nakit Akışı verileri
Metrik Eğilim 202520242023202220212020201920182017201620152014
D&A 12-point trend, +125.3% $93M $89M $83M $68M $58M $52M $55M $55M $52M $58M $45M $41M
Stock-based Comp 12-point trend, +301.2% $249M $266M $216M $188M $183M $178M $167M $148M $133M $96M $70M $62M
Deferred Tax 9-point trend, +30868.3% $248M $-86M $-159M $57M $-466M $-350.0K $-377.0K $-459.0K $-805.0K · · ·
Amort. of Intangibles 10-point trend, +111.9% $27M $24M $22M $22M $22M $22M $22M $22M $22M $13M · ·
Other Non-cash 7-point trend, -2025.4% $-463M $33M · $316M $26M $-58M $43M $24M · · · ·
Operating Cash Flow 12-point trend, +5283.5% $1.41B $335M $496M $970M $749M $-125M $711M $336M $-93M $305M $89M $26M
CapEx 9-point trend, +179.2% · · · $78M $181M $187M $78M $73M $111M $120M $26M $28M
Investing Cash Flow 11-point trend, +2.3% $-103M $158M $-208M $-79M $-208M $-269M $-87M $-86M $-350M $-232M $-105M ·
Stock Issued · · · · · · · · $649M · · ·
Stock Repurchased 4-point trend, +0.00 $0 $2.00B $0 $0 · · · · · · · ·
Net Stock Activity 3-point trend, -100.0% $0 $-2.00B · · · · · · $649M · · ·
Financing Cash Flow 11-point trend, +19.2% $101M $-2.02B $-20M $-794.0K $6M $72M $46M $15M $690M $45M $85M ·
Net Change in Cash 12-point trend, +7471.0% $1.41B $-1.53B $262M $894M $544M $-319M $669M $265M $247M $117M $69M $-19M
Taxes Paid 10-point trend, +22788.7% $212M $373M $378M $136M $68M $71M $34M $5M $6M $927.0K · ·
Free Cash Flow 7-point trend, +55168.4% · · · $892M $568M $-312M $633M $263M $-204M · · $-2M
Levered FCF 7-point trend, +1940.2% · · · $890M $565M $-315M $631M $261M $-211M · · $-48M
Kârlılık 7
INCY için Yıllık Kârlılık verileri
Metrik Eğilim 202520242023202220212020201920182017201620152014
Operating Margin 9-point trend, +3234.0% 29.5% 1.5% · 17.1% 19.6% -9.9% 18.6% 6.9% -15.9% · · -0.94%
Net Margin 7-point trend, +330.1% 25.0% 0.77% · 10.0% 31.8% -11.1% 20.7% 5.8% · · · ·
Pretax Margin 9-point trend, +441.1% 32.4% 7.5% · 15.6% 19.1% -8.7% 22.6% 6.1% -20.3% · · -9.5%
EBITDA Margin 9-point trend, +336.9% 31.3% 3.5% · 19.1% 21.6% -7.9% 21.1% 9.8% -12.5% · · 7.2%
ROA 7-point trend, +368.4% 20.8% 0.53% · 6.3% 22.3% -8.5% 14.7% 4.4% · · · ·
ROE 7-point trend, +369.5% 27.6% 0.99% · 7.9% 27.4% -11.8% 17.8% 5.9% · · · ·
ROIC 9-point trend, +2968.4% 22.7% 0.18% · 8.5% 25.8% -12.9% 14.2% 6.4% -15.0% · · -0.79%
Likidite ve Solventlik 4
INCY için Yıllık Likidite ve Solventlik verileri
Metrik Eğilim 202520242023202220212020201920182017201620152014
Current Ratio 9-point trend, +5.0% 3.3 2.0 · 3.5 3.7 3.7 4.8 4.3 4.0 · · 3.2
Quick Ratio 9-point trend, -24.6% 2.0 1.0 · 2.6 2.4 2.4 4.1 3.4 3.1 · · 2.7
Debt / Equity · · · · · · · · · · · -8.4
Interest Coverage 7-point trend, +211936.5% · · · 217.3 307.0 -121.3 216.7 83.7 -35.3 · · -0.1
Verimlilik 2
INCY için Yıllık Verimlilik verileri
Metrik Eğilim 202520242023202220212020201920182017201620152014
Asset Turnover 9-point trend, +18.3% 0.8 0.7 · 0.6 0.7 0.8 0.7 0.8 0.8 · · 0.7
Inventory Turnover 9-point trend, -40.8% 4.7 5.1 · 5.9 6.8 9.4 12.4 14.0 15.0 · · 7.9
Hisse Başına 5
INCY için Yıllık Hisse Başına verileri
Metrik Eğilim 202520242023202220212020201920182017201620152014
Book Value / Share 8-point trend, +237.3% $26.04 $17.82 · $19.62 $17.05 $11.90 $12.02 $9.03 $7.72 · · ·
Revenue / Share 8-point trend, +241.1% $25.62 $20.15 · $15.16 $13.45 $12.23 $9.92 $8.73 $7.51 · · ·
Cash Flow / Share 8-point trend, +1649.6% $7.04 $1.59 · $4.33 $3.37 $-0.57 $3.27 $1.56 $-0.45 · · ·
Cash / Share 8-point trend, +266.6% $15.61 $8.73 · $13.25 $9.31 $6.89 $8.48 $5.46 $4.26 · · ·
EPS (TTM) 12-point trend, +2310.3% $6.41 $0.15 $2.65 $1.52 $4.27 $-1.36 $2.05 $0.51 $-1.53 $0.54 $0.03 $-0.29
Büyüme Oranları 7
INCY için Yıllık Büyüme Oranları verileri
Metrik Eğilim 202520242023202220212020201920182017201620152014
Revenue YoY 5-point trend, +77.1% 21.2% 14.8% 8.9% 13.7% 12.0% · · · · · · ·
Revenue CAGR 3Y 3-point trend, +29.2% 14.8% 12.4% 11.5% · · · · · · · · ·
Revenue CAGR 5Y 14.0% · · · · · · · · · · ·
EPS YoY 4-point trend, +6580.3% 4173.3% -94.3% 74.3% -64.4% · · · · · · · ·
EPS CAGR 3Y 2-point trend, +191.5% 61.6% -67.2% · · · · · · · · · ·
Net Income YoY 4-point trend, +6099.3% 3845.0% -94.5% 75.4% -64.1% · · · · · · · ·
Net Income CAGR 3Y 2-point trend, +182.6% 55.7% -67.5% · · · · · · · · · ·
Değerleme (TTM) 10
INCY için Yıllık Değerleme (TTM) verileri
Metrik Eğilim 202520242023202220212020201920182017201620152014
Revenue TTM 12-point trend, +905.1% $5.14B $4.24B $3.70B $3.39B $2.99B $2.67B $2.16B $1.88B $1.54B $1.11B $754M $511M
Net Income TTM 10-point trend, +1134.5% $1.29B $33M $598M $341M $949M $-296M $447M $109M $-313M $104M · ·
Market Cap 8-point trend, -2.0% $19.60B $13.36B · $17.89B $16.23B $19.09B $18.88B $13.56B $20.01B · · ·
P/E 12-point trend, +106.1% 15.4 460.5 23.7 52.8 17.2 -64.0 42.6 124.7 -61.9 185.7 3615.0 -252.1
P/S 8-point trend, -70.7% 3.8 3.2 · 5.3 5.4 7.2 8.7 7.2 13.0 · · ·
P/B 8-point trend, -69.1% 3.8 3.9 · 4.1 4.3 7.3 7.3 7.0 12.3 · · ·
P / Tangible Book 6-point trend, -49.9% 3.9 4.1 2.8 4.2 4.5 7.8 · · · · · ·
P / Cash Flow 8-point trend, +106.4% 13.9 39.8 · 18.4 21.7 -153.2 26.6 40.3 -215.2 · · ·
P / FCF 6-point trend, +120.4% · · · 20.1 28.5 -61.2 29.8 51.6 -98.1 · · ·
Earnings Yield 12-point trend, +1722.5% 6.5% 0.22% 4.2% 1.9% 5.8% -1.6% 2.4% 0.80% -1.6% 0.54% 0.03% -0.40%

Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl

Gelir Tablosu
2025-12-312024-12-312023-12-312022-12-312021-12-31
Gelir $5.14B$4.24B$3.70B$3.39B$2.99B
Faaliyet Kâr Marjı % 29.5%1.5%—17.1%19.6%
Net Gelir $1.29B$33M$598M$341M$949M
Seyreltilmiş Hisse Başı Kâr $6.41$0.15$2.65$1.52$4.27
Bilanço
2025-12-312024-12-312023-12-312022-12-312021-12-31
Cari Oran 3.32.0—3.53.7
Cari Oran 2.01.0—2.62.4
Nakit Akışı
2025-12-312024-12-312023-12-312022-12-312021-12-31
Serbest Nakit Akışı ———$892M$568M

Son Haberler Bu şirketten bahseden son manşetler

İşlem Sinyalleri Giriş fiyatı ve risk/ödül oranı ile son alım/satım sinyalleri

Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar

📊

Sizin için önemli olan metrikleri seçin — yukarıdaki Tam Temeller'deki herhangi bir satırın yanındaki ➕ düğmesine tıklayın.

Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.

Kurumsal Sahipler (13F) 928 dosya · $16.2B toplam · Tarih itibarıyla 30 Haziran 2026

Çeyreklik SEC Form 13F'lerinde bu hisse senedini tuttuklarını bildiren kurumlar. Yalnızca uzun pozisyonlar; tek bir başvuru sahibi, ayrı opsiyon bacakları için iki kez görünebilir. Büyük dengeleyici alım/satım bacakları genellikle piyasa yapımını veya korunmuş envanteri yansıtır, yönlü bir inancı değil.

Kurumsal faaliyet — Q2 2026 ve önceki çeyrek
Yeni pozisyonlar Çıkan pozisyonlar Artırıldı Azaldı Net hisse senedi değişimi
123 (-1 önceki Ç'ye göre) 67 (-29 önceki Ç'ye göre) 352 (+38 önceki Ç'ye göre) 263 (-21 önceki Ç'ye göre) -2.3M

Q1 2026 ile karşılaştırıldı. SEC Form 13F başvuruları, çeyrek sonundan itibaren 45 gün içinde ve geç başvuranlar için kısa bir ek süre içinde tamamlanmalıdır — bu pencere içindeki çeyrekler, en son tam olarak raporlanan çifte tercih edilerek atlanır.

Kurum Değer Hisse senetleri % izlenen 13F'nin Tür
BAKER BROS. ADVISORS LP $3.487.217.729 30.762.330 21,55% Hisse senetleri
Dodge & Cox $1.355.482.475 11.957.326 8,38% Hisse senetleri
VANGUARD CAPITAL MANAGEMENT LLC $1.249.713.401 11.024.289 7,72% Hisse senetleri
STATE STREET CORP $1.102.124.009 9.722.336 6,81% Hisse senetleri
VANGUARD PORTFOLIO MANAGEMENT LLC $883.198.076 7.791.091 5,46% Hisse senetleri
GEODE CAPITAL MANAGEMENT, LLC $472.254.570 4.183.857 2,92% Hisse senetleri
RENAISSANCE TECHNOLOGIES LLC $398.135.284 3.512.132 2,46% Hisse senetleri
WELLINGTON MANAGEMENT GROUP LLP $384.786.803 3.394.379 2,38% Hisse senetleri
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP $311.168.439 2.744.958 1,92% Hisse senetleri
Robeco Institutional Asset Management B.V. $276.795.075 2.441.735 1,71% Hisse senetleri
TWO SIGMA INVESTMENTS, LP $227.123.448 2.003.559 1,40% Hisse senetleri
DIMENSIONAL FUND ADVISORS LP $201.199.603 1.774.874 1,24% Hisse senetleri
CHARLES SCHWAB INVESTMENT MANAGEMENT INC $191.845.249 1.692.354 1,19% Hisse senetleri
FIRST TRUST ADVISORS LP $180.015.041 1.587.996 1,11% Hisse senetleri
VICTORY CAPITAL MANAGEMENT INC $167.811.569 1.480.342 1,04% Hisse senetleri
Caisse de depot et placement du Quebec $155.360.220 1.370.503 0,96% Hisse senetleri
AustralianSuper Pty Ltd $135.634.220 1.196.491 0,84% Hisse senetleri
NORGES BANK $126.861.970 1.119.107 0,78% Hisse senetleri
FMR LLC $116.316.542 1.026.081 0,72% Hisse senetleri
ROYAL BANK OF CANADA $115.263.000 1.016.790 0,71% Hisse senetleri
VANGUARD FIDUCIARY TRUST CO $106.959.694 943.540 0,66% Hisse senetleri
ARMISTICE CAPITAL, LLC $102.024.567 900.005 0,63% Hisse senetleri
PANAGORA ASSET MANAGEMENT INC $99.970.937 881.889 0,62% Hisse senetleri
GOLDMAN SACHS GROUP INC $97.568.045 860.692 0,60% Hisse senetleri
VANGUARD GROUP INC $91.396.622 925.348 0,56% Hisse senetleri
Sound Shore Management Inc /CT/ $85.895.479 757.723 0,53% Hisse senetleri
JACOBS LEVY EQUITY MANAGEMENT, INC $82.953.901 731.774 0,51% Hisse senetleri
Gotham Asset Management, LLC $81.567.621 719.545 0,50% Hisse senetleri
Pictet Asset Management Holding SA $81.315.880 713.354 0,50% Hisse senetleri
VIRGINIA RETIREMENT SYSTEMS ET Al $75.887.460 768.325 0,47% Hisse senetleri
MACKENZIE FINANCIAL CORP $71.967.956 634.862 0,44% Hisse senetleri
LOS ANGELES CAPITAL MANAGEMENT LLC $65.633.852 578.986 0,41% Hisse senetleri
Legal & General Group Plc $63.331.398 558.675 0,39% Hisse senetleri
SEB Asset Management AB $63.307.742 558.467 0,39% Hisse senetleri
GLENMEDE TRUST CO NA $60.308.653 532.010 0,37% Hisse senetleri
Woodline Partners LP $58.118.538 512.690 0,36% Hisse senetleri
MARSHALL WACE, LLP $56.804.130 501.095 0,35% Hisse senetleri
BNP PARIBAS FINANCIAL MARKETS $56.779.870 500.881 0,35% Hisse senetleri
WORLDQUANT MILLENNIUM ADVISORS LLC $55.184.782 486.810 0,34% Hisse senetleri
BlackRock, Inc. $54.675.002 482.313 0,34% Hisse senetleri
Swiss National Bank $54.058.437 476.874 0,33% Hisse senetleri
Glenmede Investment Management, LP $53.145.338 626.640 0,33% Hisse senetleri
Vinva Investment Management Ltd $53.069.578 462.843 0,33% Hisse senetleri
CANADA PENSION PLAN INVESTMENT BOARD $50.161.800 442.500 0,31% Hisse senetleri
California Public Employees Retirement System $48.730.290 429.872 0,30% Hisse senetleri
RHUMBLINE ADVISERS $48.578.406 428.533 0,30% Hisse senetleri
IEQ CAPITAL, LLC $48.141.997 424.682 0,30% Hisse senetleri
Mitsubishi UFJ Asset Management Co., Ltd. $46.733.567 412.258 0,29% Hisse senetleri
Sumitomo Mitsui Trust Group, Inc. $44.634.140 393.738 0,28% Hisse senetleri
Vanguard Global Advisers, LLC $43.080.994 380.037 0,27% Hisse senetleri
MORGAN STANLEY $42.894.746 378.394 0,27% Hisse senetleri
Swedbank AB $42.100.431 371.387 0,26% Hisse senetleri
AMERICAN CENTURY COMPANIES INC $39.177.443 345.602 0,24% Hisse senetleri
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND $38.530.157 339.892 0,24% Hisse senetleri
CAPITAL FUND MANAGEMENT S.A. $38.125.008 336.318 0,24% Hisse senetleri
VANGUARD ASSET MANAGEMENT, Ltd $37.984.782 335.081 0,23% Hisse senetleri
Grantham, Mayo, Van Otterloo & Co. LLC $36.114.682 318.584 0,22% Hisse senetleri
Aware Super Pty Ltd as trustee of Aware Super $34.779.982 306.810 0,21% Hisse senetleri
Arbejdsmarkedets Tillaegspension $33.826.624 298.400 0,21% Hisse senetleri
BARCLAYS PLC $32.329.252 285.191 0,20% Hisse senetleri
BNP PARIBAS ASSET MANAGEMENT Holding S.A. $32.129.398 283.428 0,20% Hisse senetleri
Ensign Peak Advisors, Inc $30.602.212 269.956 0,19% Hisse senetleri
Illinois Municipal Retirement Fund $29.511.916 260.338 0,18% Hisse senetleri
WINTON GROUP Ltd $28.839.691 254.408 0,18% Hisse senetleri
PFA Pension, Forsikringsaktieselskab $28.624.373 252.509 0,18% Hisse senetleri
Universal- Beteiligungs- und Servicegesellschaft mbH $26.717.581 236.172 0,17% Hisse senetleri
TODD ASSET MANAGEMENT LLC $26.568.750 234.375 0,16% Hisse senetleri
BANK OF AMERICA CORP /DE/ $25.899.133 228.468 0,16% Hisse senetleri
PRINCIPAL FINANCIAL GROUP INC $24.961.078 220.193 0,15% Hisse senetleri
Andra AP-fonden $24.381.598 259.048 0,15% Hisse senetleri
Quantinno Capital Management LP $24.309.704 214.446 0,15% Hisse senetleri
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main $24.037.194 212.043 0,15% Hisse senetleri
Baird Financial Group, Inc. $23.690.539 208.985 0,15% Hisse senetleri
Eurizon Capital SGR S.p.A. $23.250.000 204.785 0,14% Hisse senetleri
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM $22.709.932 241.287 0,14% Hisse senetleri
Korea Investment CORP $22.164.827 195.526 0,14% Hisse senetleri
KLP KAPITALFORVALTNING AS $21.799.695 192.305 0,13% Hisse senetleri
Catalio Capital Management, LP $21.722.837 191.627 0,13% Hisse senetleri
PRUDENTIAL FINANCIAL INC $21.650.853 190.992 0,13% Hisse senetleri
ROYAL LONDON ASSET MANAGEMENT LTD $21.575.016 190.323 0,13% Hisse senetleri
Fideuram Asset Management (Ireland) dac $20.928.446 213.883 0,13% Hisse senetleri
FJARDE AP-FONDEN /FOURTH SWEDISH NATIONAL PENSION FUND $20.401.285 179.969 0,13% Hisse senetleri
APG Asset Management N.V. $20.193.310 203.661 0,12% Hisse senetleri
Zurcher Kantonalbank (Zurich Cantonalbank) $19.499.734 172.016 0,12% Hisse senetleri
SECTOR GAMMA AS $19.356.560 170.753 0,12% Hisse senetleri
MARTINGALE ASSET MANAGEMENT L P $19.137.209 168.818 0,12% Hisse senetleri
CWM, LLC $19.084.906 202.772 0,12% Hisse senetleri
Bridgewater Associates, LP $19.073.160 168.253 0,12% Hisse senetleri
ALLIANCEBERNSTEIN L.P. $18.937.791 201.209 0,12% Hisse senetleri
Candriam S.C.A. $18.443.367 162.854 0,11% Hisse senetleri
Focus Partners Wealth $18.354.947 161.917 0,11% Hisse senetleri
DNB Asset Management AS $18.304.239 161.470 0,11% Hisse senetleri
SEI INVESTMENTS CO $18.019.140 158.955 0,11% Hisse senetleri
Trails Edge Capital Partners, LP $17.570.800 155.000 0,11% Hisse senetleri
Jefferies Financial Group Inc. $17.321.295 152.799 0,11% Hisse senetleri
SAWGRASS ASSET MANAGEMENT LLC $17.250.671 152.176 0,11% Hisse senetleri
Mitsubishi UFJ Trust & Banking Corp $17.215.756 151.868 0,11% Hisse senetleri
AVIVA PLC $16.882.025 148.924 0,10% Hisse senetleri
Driehaus Capital Management LLC $16.794.397 148.151 0,10% Hisse senetleri
STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM $16.681.037 147.151 0,10% Hisse senetleri

Şirket yöneticileri 61 içeriden öğrenenler · 33 yöneticiler · 17 yönetim kurulu üyeleri

İçeriden Öğrenen Rol Son işlem Sahip olunan hisse senetleri Alımlar 12ay Satışlar 12ay Net 12ay
William Meury Chief Executive Officer 16 Temmuz 2026 A 183.129 0 0 $0
Herve Hoppenot Special Advisor to the CEO 15 Temmuz 2025 F 517.146 0 0 $0
Christiana Stamoulis EVP & Chief Financial Officer 15 Temmuz 2025 A 125.759 0 0 $0
David W Gryska Executive Vice President, CFO 16 Temmuz 2018 F 10.235 0 0 $0
David C Hastings Chief Financial Officer 05 Haziran 2014 M 8.500 0 0 $0
Pablo J Cagnoni President, Global Head of R&D 19 Ağustos 2026 S 183.200 0 7 $-11.304.514
Lee Heeson EVP, Head of Incyte Intl 23 Temmuz 2026 A 32.778 0 0 $0
Michael James Morrissey EVP, Head of Tech. Operations 23 Temmuz 2026 A 81.515 0 0 $0
Richard A. Hoffman EVP & General Counsel 16 Temmuz 2026 A 16.861 0 0 $0
David H Gardner EVP, Chief Strategy Officer 16 Temmuz 2026 A 16.824 0 0 $0
Ramitpal K Basi EVP, Human Resources 16 Temmuz 2026 A 11.497 0 0 $0
Mohamed Khairie Issa EVP, Head of U.S. Commercial 16 Temmuz 2026 A 71.797 0 1 $-125.706
Thomas Tray Principal Accounting Officer 16 Temmuz 2026 A 21.699 0 1 $-263.900
Steven H Stein CMO & Head of Late-Stage Dev. 16 Temmuz 2026 A 30.916 0 2 $-3.407.541
Sheila A. Denton EVP & General Counsel 15 Ağustos 2025 M 33.200 0 0 $0
Vijay K Iyengar EVP, GMAPPS 16 Temmuz 2025 S 40.540 0 0 $0
Barry P Flannelly EVP & General Manager US 16 Temmuz 2025 S 35.149 0 0 $0
Matteo Trotta EVP, GM, Dermatology US 15 Temmuz 2025 A 15.016 0 0 $0
Paula J Swain EVP, Human Resources 15 Temmuz 2025 A 106.482 0 0 $0
Jonathan Elliott Dickinson EVP, General Manager, Europe 12 Eylül 2024 S 36.390 0 0 $0
Dashyant Dhanak EVP & Chief Scientific Officer 14 Temmuz 2023 A 58.968 0 0 $0
Maria E Pasquale EVP & General Counsel 14 Temmuz 2023 A 69.724 0 0 $0
Paul Trower Principal Accounting Officer 19 Ocak 2022 A 32.268 0 0 $0
Yao Wenqing EVP, Head of Discovery Chem 02 Temmuz 2021 A 98.575 0 0 $0
Reid M Huber EVP, Chief Scientific Officer 16 Temmuz 2018 F 34.571 0 0 $0
Eric H. Siegel EVP, General Counsel 13 Eylül 2017 F 21.053 0 0 $0
Richard S Levy EVP, Chief Drug Dev Officer 06 Ocak 2016 M 16.926 0 0 $0
James M Daly EVP, Chief Commercial Officer 23 Haziran 2015 M 3.521 0 0 $0
Patricia S Andrews Chief Commercial Officer 19 Ocak 2012 A — 0 0 $0
Patricia A Schreck EVP, General Counsel 10 Mayıs 2011 M 4.500 0 0 $0
Brian W Metcalf Chief Drug Discovery Scientist 11 Nisan 2011 M 66.504 0 0 $0
Steven M. Friedman EVP, Biology & Preclinical Dev 18 Mayıs 2010 A 38.137 0 0 $0
John A Keller Chief Business Officer 08 Şubat 2008 A — 0 0 $0
Paul J Clancy Yönetim kurulu üyesi 30 Haziran 2026 A 25.635 0 1 $-1.423.950
Edmund Harrigan Yönetim kurulu üyesi 30 Haziran 2026 A 23.019 0 0 $0
Katherine A High Yönetim kurulu üyesi 08 Haziran 2026 A 14.983 0 0 $0
Jacqualyn A Fouse Yönetim kurulu üyesi 08 Haziran 2026 A 20.968 0 0 $0
Jean Jacques Bienaime Yönetim kurulu üyesi 08 Haziran 2026 A 24.424 0 0 $0
Otis W Brawley Yönetim kurulu üyesi 08 Haziran 2026 A 12.894 0 0 $0
Susanne Schaffert Yönetim kurulu üyesi 12 Haziran 2024 A 5.720 0 0 $0
Wendy L Dixon Yönetim kurulu üyesi 31 Mart 2022 A 17.768 0 0 $0
Paul A Friedman, M.D. Yönetim kurulu üyesi 26 Mayıs 2020 A 256.813 0 0 $0
Paul A Brooke Yönetim kurulu üyesi 31 Mart 2020 A 221.911 0 0 $0
Barry A Ariko Yönetim kurulu üyesi 12 Mart 2015 M 45.834 0 0 $0
Richard U De Schutter Yönetim kurulu üyesi 05 Mart 2015 M 92.290 0 0 $0
Roy A Whitfield Yönetim kurulu üyesi 17 Aralık 2013 M 666.082 0 0 $0
John F Niblack Yönetim kurulu üyesi 20 Mayıs 2011 A — 0 0 $0
Fred B Craves Yönetim kurulu üyesi 01 Haziran 2005 A 196.793 0 0 $0
INCYTE CORP 10% sahip 25 Ocak 2021 A 3.550.000 0 0 $0
DAMIAL FOUNDATION INC 10% sahip 11 Şubat 2004 S — 0 0 $0

SEC Form 3/4/5 başvurularından yöneticiler; net = yalnızca açık piyasa Alış/Satış

Aktivistler ve %5+ sahipler 7 pozisyon

SEC Çizelge 13D dosyalayan yatırımcılar — ihraççı üzerinde nüfuz etme niyetiyle %5'in üzerinde faydalı sahiplik (aktivist hisseler, yönetim kurulu kampanyaları, M&A). Her satır, o başvuru sahibinin pozisyonunun bilinen en son durumunu gösterir.

Başvuru sahibi Dosyalandı Hisse Durum Amaç Başvuru
Baker Bros. Advisors LP, Baker Bros. Advisors (GP) LLC, Julian C. Baker, Felix J. Baker, FBB2, LLC, FBB3 LLC, FBB Associates ×21 başvurular 11 Mayıs 2026 15,60% Değişiklik Pasif yatırım SEC
Incyte Corporation ×3 başvurular 14 Ağustos 2023 — İlk başvuru Sermaye yapısı SEC
Baker Bros. Advisors, LLC, Julian C. Baker, Felix J. Baker, FBB2, LLC, FBB Associates ×2 başvurular 15 Haziran 2012 — İlk başvuru — SEC
Julian C. Baker, Felix J. Baker ×12 başvurular 01 Ekim 2009 — İlk başvuru — SEC
Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi 25 Şubat 2004 — İlk başvuru — SEC
Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi 29 Eylül 2003 — İlk başvuru — SEC
Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi 15 Ağustos 2002 — İlk başvuru — SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

ETF sahipliği 213 ETF'ler tarafından tutuluyor

Ağırlık yalnızca doğrudan öz sermaye varlıklarını (N-PORT) yansıtır; kaldıraçlı veya türev tabanlı fonlar gösterilmeyen ek swap pozisyonlarına sahip olabilir.

Fon Ağırlık Birimler Tarih itibarıyla Kaynak
IDNA · iShares Trust 3,94% 71.574 SH 19 Ağustos 2026 Günlük
BRNY · EA Series Trust 3,64% 211.562 NS 30 Nisan 2026 N-PORT
PBE · Invesco Exchange-Traded Fund Trust 2,97% 93.433 SH 19 Ağustos 2026 Günlük
UPGD · Invesco Exchange-Traded Fund Trust 2,40% 23.365 SH 19 Ağustos 2026 Günlük
BUL · Pacer Funds Trust 2,38% 31.787 NS 30 Nisan 2026 N-PORT
SAWG · ETF Series Solutions 2,36% 624 NS 30 Nisan 2026 N-PORT
FXH · First Trust Exchange-Traded AlphaDE… 2,19% 201.047 NS 30 Nisan 2026 N-PORT
FGSI · First Trust Exchange-Traded Fund IV 1,98% 623 NS 30 Nisan 2026 N-PORT
SMRI · EA Series Trust 1,96% 111.283 NS 30 Nisan 2026 N-PORT
SPGP · Invesco Exchange-Traded Fund Trust 1,80% 336.668 SH 19 Ağustos 2026 Günlük
IBB · iShares Trust 1,78% 1.469.660 SH 19 Ağustos 2026 Günlük
HTEC · EXCHANGE TRADED CONCEPTS TRUST 1,78% 9.967 NS 30 Nisan 2026 N-PORT
RPG · Invesco Exchange-Traded Fund Trust 1,77% 286.479 SH 19 Ağustos 2026 Günlük
RSPH · Invesco Exchange-Traded Fund Trust 1,75% 112.115 SH 19 Ağustos 2026 Günlük
IBBQ · Invesco Exchange-Traded Fund Trust … 1,64% 11.057 SH 19 Ağustos 2026 Günlük
BBP · ETFis Series Trust I 1,59% 9.918 NS 30 Nisan 2026 N-PORT
ABOT · Abacus FCF ETF Trust 1,59% 736 NS 30 Nisan 2026 N-PORT
CALF · Pacer Funds Trust 1,55% 561.166 NS 30 Nisan 2026 N-PORT
NUMG · Nushares ETF Trust 1,44% 53.580 NS 30 Nisan 2026 N-PORT
AGNG · Global X Funds 1,36% 11.515 NS 31 Mayıs 2026 N-PORT
COWG · Pacer Funds Trust 1,21% 275.493 NS 30 Nisan 2026 N-PORT
QQQJ · Invesco Exchange-Traded Fund Trust … 1,20% 115.850 SH 19 Ağustos 2026 Günlük
FLOW · Global X Funds 1,20% 3.543 NS 31 Mayıs 2026 N-PORT
GURU · Global X Funds 1,01% 6.203 NS 30 Nisan 2026 N-PORT
BIB · ProShares Trust 0,97% 7.359 NS 31 Mayıs 2026 N-PORT
LABU · Direxion Shares ETF Trust 0,94% 51.287 NS 30 Nisan 2026 N-PORT
TMFX · RBB Fund, Inc. 0,94% 3.113 NS 31 Mayıs 2026 N-PORT
OASC · Unified Series Trust 0,91% 7.915 NS 31 Mayıs 2026 N-PORT
LSVD · ADVISORS' INNER CIRCLE FUND 0,89% 56.482 NS 30 Nisan 2026 N-PORT
ROE · EA Series Trust 0,87% 23.347 NS 29 Mayıs 2026 N-PORT
JMID · Janus Detroit Street Trust 0,83% 1.595 NS 30 Nisan 2026 N-PORT
SPVM · Invesco Exchange-Traded Fund Trust 0,81% 9.062 SH 19 Ağustos 2026 Günlük
JOET · Virtus ETF Trust II 0,79% 19.541 NS 30 Nisan 2026 N-PORT
INFO · Harbor ETF Trust 0,75% 61.119 NS 30 Nisan 2026 N-PORT
SDG · iShares Trust 0,72% 10.188 SH 19 Ağustos 2026 Günlük
CLSE · Trust for Professional Managers 0,71% 45.326 NS 31 Mayıs 2026 N-PORT
FTC · First Trust Exchange-Traded AlphaDE… 0,64% 85.796 NS 30 Nisan 2026 N-PORT
QGRO · AMERICAN CENTURY ETF TRUST 0,64% 146.423 NS 31 Mayıs 2026 N-PORT
VBK · VANGUARD INDEX FUNDS 0,53% 2.249.253 SH 19 Ağustos 2026 Günlük
ESMV · iShares Trust 0,53% 339 SH 19 Ağustos 2026 Günlük
EBI · RBB Fund Trust 0,52% 35.279 NS 31 Mayıs 2026 N-PORT
TECB · iShares Trust 0,49% 19.516 SH 19 Ağustos 2026 Günlük
AFMC · First Trust Exchange-Traded Fund VI… 0,48% 7.994 NS 31 Mayıs 2026 N-PORT
USMV · iShares Trust 0,47% 908.964 SH 19 Ağustos 2026 Günlük
VFQY · VANGUARD WELLINGTON FUND 0,46% 19.147 SH 19 Ağustos 2026 Günlük
AFLG · First Trust Exchange-Traded Fund VI… 0,45% 29.860 NS 31 Mayıs 2026 N-PORT
FLCV · Federated Hermes ETF Trust 0,44% 4.411 NS 31 Mayıs 2026 N-PORT
COWZ · Pacer Funds Trust 0,44% 832.413 NS 30 Nisan 2026 N-PORT
QQWZ · Pacer Funds Trust 0,43% 2.130 NS 30 Nisan 2026 N-PORT
HQGO · Lattice Strategies Trust 0,42% 2.110 NS 30 Nisan 2026 N-PORT